Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.

Vilsbøll, T; Brock, B; Perrild, H; Levin, K; Lervang, H-H; Kølendorf, K; Krarup, T; Schmitz, O; Zdravkovic, M; Le-Thi, T; Madsbad, S

Vilsbøll, T; Brock, B; Perrild, H; Levin, K; Lervang, H-H; Kølendorf, K; Krarup, T; Schmitz, O; Zdravkovic, M; Le-Thi, T; Madsbad, S.

Affiliation

Vilsbøll T; Department of Internal Medicine F, Gentofte Hospital, Gentofte, Denmark. t.vilsboll@dadlnet.dk

Diabet Med ; 25(2): 152-6, 2008 Feb.

Article in En | MEDLINE | ID: mdl-18201212

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Glucagon-Like Peptide 1/analogs & derivatives; Hypoglycemic Agents/therapeutic use; Islets of Langerhans/metabolism; Receptors, Glucagon/metabolism; C-Peptide/metabolism; Diabetes Mellitus, Type 2/metabolism; Drug Administration Schedule; Female; Glucagon-Like Peptide 1/therapeutic use; Humans; Incretins/metabolism; Insulin Resistance; Liraglutide; Male; Middle Aged; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Islets of Langerhans / Receptors, Glucagon / Diabetes Mellitus, Type 2 / Glucagon-Like Peptide 1 / Hypoglycemic Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2008 Document type: Article Affiliation country: Denmark Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google